SYHA1813, CAS 1807466-30-3

Product Description: SYHA1813 is a dual inhibitor of CSF1R and VEGFR. SYHA1813 has potent antitumor activity against GBM[1].

Applications: Cancer-Kinase/protease

Formula: C25H19FN4O

References: [1]Yingqiang Liu, et al. Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma. Acta Pharm Sin B. 2023, 13,12.

CAS Number: 1807466-30-3

Molecular Weight: 410.44

Compound Purity: 99.22

Research Area: Cancer

Solubility: DMSO : 125 mg/mL (ultrasonic)

Target: c-Fms;VEGFR

• Artikelnummer: MEXHY-161025-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-161025-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK